On November 28, 2025, Dogwood Therapeutics, Inc. entered into an equity distribution agreement to sell up to $8,558,712 of its common stock through Northland Securities, Inc. as the sales agent, which represents 21.38% of the company's outstanding stock held by non-affiliates.